U.S. exports of pharmaceuticals and medicines to China, meanwhile, rose 38% last year, according to the U.S.-China Business Council. But drugmakers’ entry to the vast Chinese market also comes at a cost, as authorities drive a hard bargain in a bid to make drugs affordable, and local competition is fierce.